Feasibility study of opioid-induced nausea and vomiting
Not Applicable
- Conditions
- Opioid-induced nausea and vomiting (OINV)
- Registration Number
- JPRN-UMIN000031741
- Lead Sponsor
- Teikyo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1) Brain metastasis with edema or meningeal carcinomatosis 2)Peritoneal dissemination, intestinal obstruction or intestinal stenosis with intestinal dilation 3) Constipation >= Grade 3 4) History of diabetes requiring medication 5) Administration of antineoplastic agents with high or moderate emetic risk within 21 days 6) Administration of antineoplastic agents with low emetic risk within 7 days 7) Abdominal surgery within 21 days 8) Infection requiring systemic treatment 9) Active peptic ulcer 10) History of HBV infection 11) Delirium within 1 year 12) History of steroid psychosis 13) Allergy to dexamethasone 14) Other conditions inappropriate for participating in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete response rate at 72 hour after initiation of opioids
- Secondary Outcome Measures
Name Time Method